Publication Information

{'id': 'https://openalex.org/W2035474792', 'doi': 'https://doi.org/10.1517/13543784.17.6.845', 'title': 'Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes', 'display_name': 'Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes', 'publication_year': 2008, 'publication_date': '2008-05-21', 'ids': {'openalex': 'https://openalex.org/W2035474792', 'doi': 'https://doi.org/10.1517/13543784.17.6.845', 'mag': '2035474792', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18491986'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.17.6.845', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5089314378', 'display_name': 'Nasser Mikhail', 'orcid': 'https://orcid.org/0000-0002-7269-9338'}, 'institutions': [{'id': 'https://openalex.org/I4210130891', 'display_name': 'Olive View-UCLA Medical Center', 'ror': 'https://ror.org/03b66rp04', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1328359107', 'https://openalex.org/I4210130891']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Nasser Mikhail', 'raw_affiliation_strings': ['+1 818 364 4573', 'Endocrinology Division, Department of Medicine, Olive-View-UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA +1 818 364 3205'], 'affiliations': [{'raw_affiliation_string': '+1 818 364 4573', 'institution_ids': []}, {'raw_affiliation_string': 'Endocrinology Division, Department of Medicine, Olive-View-UCLA Medical Center, 14445 Olive View Drive, Sylmar, CA 91342, USA +1 818 364 3205', 'institution_ids': ['https://openalex.org/I4210130891']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5089314378'], 'corresponding_institution_ids': ['https://openalex.org/I4210130891'], 'apc_list': None, 'apc_paid': None, 'fwci': 1.642, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 60, 'citation_normalized_percentile': {'value': 0.535615, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '17', 'issue': '6', 'first_page': '845', 'last_page': '853'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10839', 'display_name': 'Pancreatic function and diabetes', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Metabolism, Diabetes, and Cancer', 'score': 0.9927, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/incretin', 'display_name': 'Incretin', 'score': 0.90303034}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase', 'display_name': 'Dipeptidyl peptidase', 'score': 0.7129474}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitor', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'score': 0.43388987}, {'id': 'https://openalex.org/keywords/vildagliptin', 'display_name': 'Vildagliptin', 'score': 0.4102878}], 'concepts': [{'id': 'https://openalex.org/C2778881409', 'wikidata': 'https://www.wikidata.org/wiki/Q1420402', 'display_name': 'Incretin', 'level': 4, 'score': 0.90303034}, {'id': 'https://openalex.org/C2781469919', 'wikidata': 'https://www.wikidata.org/wiki/Q5279728', 'display_name': 'Dipeptidyl peptidase', 'level': 3, 'score': 0.7129474}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.7052863}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.6707551}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5680548}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.5465349}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5389979}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.51038593}, {'id': 'https://openalex.org/C2910068830', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 Diabetes Mellitus', 'level': 3, 'score': 0.4721185}, {'id': 'https://openalex.org/C2776398474', 'wikidata': 'https://www.wikidata.org/wiki/Q424611', 'display_name': 'Glucagon-like peptide-1', 'level': 4, 'score': 0.4697704}, {'id': 'https://openalex.org/C2778763485', 'wikidata': 'https://www.wikidata.org/wiki/Q419770', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'level': 4, 'score': 0.43388987}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.42368528}, {'id': 'https://openalex.org/C2776453732', 'wikidata': 'https://www.wikidata.org/wiki/Q421042', 'display_name': 'Vildagliptin', 'level': 4, 'score': 0.4102878}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.30566415}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.27945772}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.22502255}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.17193463}], 'mesh': [{'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D054795', 'descriptor_name': 'Incretins', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010455', 'descriptor_name': 'Peptides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014688', 'descriptor_name': 'Venoms', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001835', 'descriptor_name': 'Body Weight', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001835', 'descriptor_name': 'Body Weight', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017326', 'descriptor_name': 'Clinical Trials, Phase III as Topic', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': False}, {'descriptor_ui': 'D017326', 'descriptor_name': 'Clinical Trials, Phase III as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018819', 'descriptor_name': 'Dipeptidyl Peptidase 4', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D054873', 'descriptor_name': 'Dipeptidyl-Peptidase IV Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077270', 'descriptor_name': 'Exenatide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D052216', 'descriptor_name': 'Glucagon-Like Peptide 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000067757', 'descriptor_name': 'Glucagon-Like Peptide-1 Receptor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006442', 'descriptor_name': 'Glycated Hemoglobin A', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006442', 'descriptor_name': 'Glycated Hemoglobin A', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007003', 'descriptor_name': 'Hypoglycemia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007003', 'descriptor_name': 'Hypoglycemia', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D054795', 'descriptor_name': 'Incretins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007328', 'descriptor_name': 'Insulin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007328', 'descriptor_name': 'Insulin', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D007328', 'descriptor_name': 'Insulin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000078790', 'descriptor_name': 'Insulin Secretion', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010455', 'descriptor_name': 'Peptides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D010455', 'descriptor_name': 'Peptides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010455', 'descriptor_name': 'Peptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018027', 'descriptor_name': 'Receptors, Glucagon', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018027', 'descriptor_name': 'Receptors, Glucagon', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D000068900', 'descriptor_name': 'Sitagliptin Phosphate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014688', 'descriptor_name': 'Venoms', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014688', 'descriptor_name': 'Venoms', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D014688', 'descriptor_name': 'Venoms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077597', 'descriptor_name': 'Vildagliptin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.17.6.845', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18491986', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.82, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 64, 'referenced_works': ['https://openalex.org/W1590228841', 'https://openalex.org/W1969389642', 'https://openalex.org/W1969932276', 'https://openalex.org/W1970406523', 'https://openalex.org/W1977119153', 'https://openalex.org/W1977619586', 'https://openalex.org/W1984588810', 'https://openalex.org/W1984740259', 'https://openalex.org/W1986085856', 'https://openalex.org/W1989976483', 'https://openalex.org/W1994832750', 'https://openalex.org/W2000465889', 'https://openalex.org/W2001097346', 'https://openalex.org/W2018192866', 'https://openalex.org/W2020638064', 'https://openalex.org/W2024409703', 'https://openalex.org/W2027249582', 'https://openalex.org/W2028272916', 'https://openalex.org/W2037839438', 'https://openalex.org/W2044511675', 'https://openalex.org/W2045923887', 'https://openalex.org/W2047353065', 'https://openalex.org/W2050826565', 'https://openalex.org/W2051462052', 'https://openalex.org/W2059158127', 'https://openalex.org/W2061244748', 'https://openalex.org/W2069375870', 'https://openalex.org/W2074956966', 'https://openalex.org/W2076998384', 'https://openalex.org/W2078387216', 'https://openalex.org/W2079787842', 'https://openalex.org/W2080128749', 'https://openalex.org/W2085862152', 'https://openalex.org/W2085912144', 'https://openalex.org/W2089304685', 'https://openalex.org/W2093738306', 'https://openalex.org/W2099677425', 'https://openalex.org/W2106558322', 'https://openalex.org/W2111242088', 'https://openalex.org/W2113901579', 'https://openalex.org/W2115707749', 'https://openalex.org/W2120774442', 'https://openalex.org/W2123355624', 'https://openalex.org/W2126520659', 'https://openalex.org/W2127409471', 'https://openalex.org/W2129377335', 'https://openalex.org/W2129546109', 'https://openalex.org/W2143612861', 'https://openalex.org/W2145335273', 'https://openalex.org/W2147779427', 'https://openalex.org/W2153449155', 'https://openalex.org/W2157841460', 'https://openalex.org/W2159205789', 'https://openalex.org/W2162934281', 'https://openalex.org/W2163918978', 'https://openalex.org/W2164416879', 'https://openalex.org/W2164961795', 'https://openalex.org/W2167621077', 'https://openalex.org/W2171512247', 'https://openalex.org/W2325963726', 'https://openalex.org/W2415833552', 'https://openalex.org/W2416208874', 'https://openalex.org/W4210559565', 'https://openalex.org/W4285719527'], 'related_works': ['https://openalex.org/W3196981546', 'https://openalex.org/W3130111505', 'https://openalex.org/W3083950790', 'https://openalex.org/W2460093818', 'https://openalex.org/W2331130036', 'https://openalex.org/W2143220697', 'https://openalex.org/W2135193404', 'https://openalex.org/W2030477680', 'https://openalex.org/W1968524774', 'https://openalex.org/W1483551457'], 'abstract_inverted_index': {'Background:': [0], 'Exenatide': [1, 127], 'is': [2, 79, 103, 116, 217, 226, 237], 'an': [3], 'incretin': [4, 11], 'mimetic,': [5], 'while': [6], 'sitagliptin': [7, 55, 100, 143, 205, 262], 'and': [8, 27, 56, 119, 144, 153, 180, 193, 206, 231, 246, 261], 'vildagliptin': [9, 28, 102, 145, 154, 207, 247], 'are': [10, 155, 185, 208], 'enhancers': [12], 'used': [13, 32, 123, 250, 265], 'as': [14, 33, 196, 198, 251, 266], 'adjunctive': [15], 'therapy': [16, 211], 'in': [17, 35, 83, 158, 253, 270], 'patients': [18, 36, 170, 254], 'with': [19, 37, 81, 93, 98, 124], 'type': [20, 38, 213], '2': [21, 39, 137, 214], 'diabetes': [22, 40, 215], 'failing': [23], 'oral': [24, 221], 'agents.': [25], 'Sitagliptin': [26, 152, 245], 'can': [29], 'also': [30], 'be': [31, 249, 264], 'monotherapy': [34, 252], 'uncontrolled': [41], 'by': [42, 187, 199], 'diet.': [43], 'Objective:': [44], 'To': [45], 'provide': [46], 'a': [47, 131], 'critical': [48], 'review': [49], 'of': [50, 53, 60, 77, 89, 107, 135, 169, 190, 241], 'clinical': [51, 63], 'trials': [52, 64, 159], 'exenatide,': [54], 'vildagliptin.': [57], 'Method:': [58], 'Review': [59], 'Phase': [61], 'III': [62], 'based': [65], 'on': [66, 150, 220], 'Medline': [67], 'search': [68], 'published': [69], 'up': [70, 161], 'to': [71, 130, 162, 175, 268], 'April': [72], '2008.': [73], 'Results:': [74], 'The': [75, 95, 105, 182], 'use': [76], 'exenatide': [78, 173], 'associated': [80], 'reduction': [82, 97], 'average': [84], 'hemoglobin': [85], 'A1c': [86], '(HbA1c)': [87], 'levels': [88], 'approximately': [90], '0.8%': [91], 'compared': [92], 'baseline.': [94], 'corresponding': [96], 'either': [99], 'or': [101, 233, 259], '0.7%.': [104], 'actions': [106], 'incretin-based': [108], 'drugs': [109, 184], 'predominantly': [110], 'target': [111], 'postprandial': [112, 235], 'hyperglycemia.': [113], 'Treatment-related': [114], 'hypoglycemia': [115], 'generally': [117, 147], 'mild,': [118], 'mainly': [120, 178], 'occurs': [121], 'when': [122, 224, 234], 'sulfonylureas': [125], '(SUs).': [126], 'treatment': [128], 'leads': [129], 'mild': [132], 'weight': [133, 229], 'loss': [134], 'around': [136], 'kg': [138], 'after': [139], '30': [140], 'weeks,': [141], 'whereas': [142], 'have': [146], 'neutral': [148], 'effect': [149], 'weight.': [151], 'well': [156, 197], 'tolerated': [157], 'lasting': [160], '52': [163], 'weeks.': [164], 'Meanwhile,': [165], '5': [166], '–': [167], '10%': [168], 'cannot': [171, 256], 'tolerate': [172, 257], 'due': [174], 'adverse': [176], 'effects,': [177], 'nausea': [179], 'vomiting.': [181], 'three': [183], 'limited': [186], 'the': [188, 238], 'lack': [189], 'long-term': [191], 'safety': [192], 'efficacy': [194], 'data,': [195], 'their': [200], 'high': [201], 'cost.': [202], 'Conclusion:': [203], 'Exenatide,': [204], 'useful': [209], 'add-on': [210], 'for': [212], 'that': [216], 'suboptimally': [218], 'controlled': [219], 'agents,': [222], 'particularly': [223], 'there': [225], 'concern': [227], 'about': [228], 'gain': [230], 'hypoglycemia,': [232], 'hyperglycemia': [236], 'major': [239], 'cause': [240], 'inadequate': [242], 'glycemic': [243], 'control.': [244], 'may': [248, 263], 'who': [255], 'metformin': [258, 269], 'SU,': [260], 'alternative': [267], 'renal': [271], 'insufficiency.': [272]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2035474792', 'counts_by_year': [{'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 7}, {'year': 2012, 'cited_by_count': 6}], 'updated_date': '2024-12-11T14:07:33.632008', 'created_date': '2016-06-24'}